Quadrature Capital Ltd Trims Stock Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Quadrature Capital Ltd cut its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 12.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,639 shares of the medical instruments supplier’s stock after selling 1,724 shares during the period. Quadrature Capital Ltd owned approximately 0.32% of Utah Medical Products worth $985,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of UTMD. Penn Mutual Asset Management LLC raised its stake in Utah Medical Products by 46.3% during the fourth quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after purchasing an additional 16,810 shares during the period. Natixis Advisors L.P. purchased a new stake in shares of Utah Medical Products in the 3rd quarter valued at approximately $1,102,000. FMR LLC raised its stake in shares of Utah Medical Products by 2.0% in the 3rd quarter. FMR LLC now owns 389,831 shares of the medical instruments supplier’s stock valued at $33,525,000 after acquiring an additional 7,738 shares during the period. Brandes Investment Partners LP raised its stake in shares of Utah Medical Products by 21.2% in the 4th quarter. Brandes Investment Partners LP now owns 32,825 shares of the medical instruments supplier’s stock valued at $2,765,000 after acquiring an additional 5,746 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in shares of Utah Medical Products in the 3rd quarter valued at approximately $319,000. 69.60% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Stock Performance

Shares of UTMD stock opened at $67.03 on Friday. The stock has a market capitalization of $236.62 million, a P/E ratio of 14.90 and a beta of 0.14. The company has a 50 day moving average price of $67.85 and a 200 day moving average price of $73.46. Utah Medical Products, Inc. has a fifty-two week low of $65.91 and a fifty-two week high of $99.46.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, April 25th. The medical instruments supplier reported $1.09 earnings per share for the quarter. Utah Medical Products had a net margin of 33.40% and a return on equity of 13.06%. The firm had revenue of $11.34 million during the quarter.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 5th. Shareholders of record on Friday, June 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.79%. The ex-dividend date is Friday, June 14th. Utah Medical Products’s dividend payout ratio (DPR) is presently 26.67%.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.